Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

October 9, 2025

Study Completion Date

October 9, 2025

Conditions
Vitiligo
Interventions
PROCEDURE

SKIN SAMPLES

"At baseline: one 4 mm Ø skin biopsies: on forearms (excluding skin folds): fresh At month 3 and month 6: Two 4 mm Ø skin biopsies will be performed on the same lesion selected at baseline (one on a repigmented area, one on a non-responded area): fresh~Fresh Skin biopsies will be analyzed the same day using Single-cell RNA sequencing (scRNAseq)."

PROCEDURE

BLOOD SAMPLES

Blood samples will be taken (30 mL) at week 0, week 12, week 24 for the measurement of pro-inflammatory cytokines and chemokines ligands in blood sera.

DEVICE

narrowband UVB

narrowband UVB (Nb-UVB) 2 times a week

DRUG

Systemic Steroids

Oral minipuls of systemic steroids (Medrol 16mg twice a week) for 24 weeks

Trial Locations (1)

33000

RECRUITING

University Hospital of Bordeaux - St André Hospital, Bordeaux

All Listed Sponsors
collaborator

Centre National de la Recherche Scientifique, France

OTHER

lead

University Hospital, Bordeaux

OTHER